Trade Summary

3 days ago, Culverwell Anthony James, serving as Dir at Quoin Pharmaceuticals, Ltd. (QNRX), purchased 6,146 shares at $4.88 per share, for a total transaction value of $29,992.48. Following this transaction, Culverwell Anthony James now holds 40,364 shares of QNRX.

This purchase represents a 17.96% increase in Culverwell Anthony James's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Monday, August 31, 2026 and publicly disclosed via SEC Form 4 filing on Wednesday, September 2, 2026 (accepted Sep 1, 9:38 PM ET), 2 days after the trade was made.

Quoin Pharmaceuticals, Ltd. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider buying activity in this sector can provide valuable signals about industry trends and company-specific developments.